Literature DB >> 2480679

Maintaining quality of life after palliative diversion for malignant ureteral obstruction.

D M Markowitz1, K T Wong, K J Laffey, R Bixon, H M Nagler, E C Martin.   

Abstract

The records of 71 consecutive patients who underwent percutaneous nephrostomy for malignant ureteral obstruction were reviewed. The average post-nephrostomy survival time was seven months, of which 25% was spent in the hospital. When comparing these figures to older studies of open nephrostomy, the percutaneous procedure is associated with less morbidity and an increased percentage of time spent at home (75% compared to 36%). Long-term survival, however, is still poor, with only 25% of patients alive at one year. We suggest that the criteria previously adopted for open nephrostomy generally remain appropriate for patients being considered for percutaneous urinary diversion.

Entities:  

Mesh:

Year:  1989        PMID: 2480679     DOI: 10.1007/bf02926495

Source DB:  PubMed          Journal:  Urol Radiol        ISSN: 0171-1091


  4 in total

Review 1.  Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.

Authors:  Klaus Armin Hausegger; Horst Rupert Portugaller
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

2.  In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections.

Authors:  Nylev Vargas-Cruz; Ruth A Reitzel; Joel Rosenblatt; Mohamed Jamal; Ariel D Szvalb; Anne-Marie Chaftari; Ray Hachem; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Change of Renal Parenchymal Width in Patients with Unilateral Ureteral Stent: A Bicenter Retrospective Study.

Authors:  Hee Youn Kim; Seung-Ju Lee; Jin Bong Choi; Je Mo Yoo; Joon Ho Lee; Dong Sup Lee
Journal:  Biomed Res Int       Date:  2017-06-01       Impact factor: 3.411

4.  Ureterolysis with ureterotomy and omental sleeve wrap in patients with radiation induced pelvic retroperitoneal fibrosis.

Authors:  Endre Zoltan Neulander; Inoel Rivera; Jacob Kaneti; Zev Wajsman
Journal:  Cent European J Urol       Date:  2019-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.